This inventor holds 2 USPTO granted patents. Top assignee: Massachusetts Institute of Technology. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Lei Miao: Innovator in Lipidoid Compounds
Introduction
Lei Miao is a prominent inventor based in San Jose, CA, known for his contributions to the field of lipidoid compounds. He holds 2 patents that focus on innovative methods and compositions for treating various diseases. His work is significant in the realm of pharmaceutical applications, particularly in the delivery of therapeutic agents.
Latest Patents
Miao's latest patents include groundbreaking research on ionizable lipidoids and their uses. These patents describe lipidoid compounds of specific formulae, along with their pharmaceutically acceptable salts, co-crystals, tautomers, stereoisomers, solvates, hydrates, polymorphs, isotopically labeled derivatives, and prodrugs. The patents also detail methods and kits that utilize these lipidoid compounds for treating and preventing a wide range of diseases, including genetic, neurological, and autoimmune disorders. The compounds are designed to be effective carriers for delivering agents such as polynucleotides, including RNA, to cells.
Career Highlights
Lei Miao is affiliated with the Massachusetts Institute of Technology, where he continues to advance his research in lipidoid compounds. His innovative work has positioned him as a key figure in the development of new therapeutic strategies.
Collaborations
Miao collaborates with notable colleagues, including Daniel Griffith Anderson and Yuxuan Huang, who contribute to his research endeavors.
Conclusion
In summary, Lei Miao is an influential inventor whose work on lipidoid compounds has the potential to revolutionize treatment methods for various diseases. His contributions to the field are invaluable and continue to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
